NCT07476378 2026-03-17
Archonc-001
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Not yet recruiting
Clinical Trials
41 trialsNCT07451197 2026-03-05
Family-Focused Study to Support Medication for Opioid Use Disorder
University of Wisconsin, Madison
Phase NA Not yet recruiting
NCT07101328 2026-03-04
BAF_FRontier-1
Eli Lilly and Company
Phase 1 Not yet recruiting
NCT07422610 2026-02-20
Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment
Novartis
Phase 1 Not yet recruiting
NCT07424833 2026-02-20
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Ascentage Pharma Group Inc.
Phase 1 Not yet recruiting
NCT07420062 2026-02-19
RSWITCH
International Food Policy Research Institute
Phase NA Not yet recruiting
NCT07410052 2026-02-13
MENTOR
Center for Health Sciences, Serbia
Phase NA Not yet recruiting
NCT07355283 2026-01-27
IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 3 Not yet recruiting
NCT07167862 2026-01-23
PPPOCUS
University of California, Irvine
Phase 4 Not yet recruiting
NCT07360288 2026-01-22
TC011_FL_201
TICAROS Co., Ltd.
Phase 2 Not yet recruiting
NCT07343934 2026-01-15
huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
University of Pennsylvania
Phase 1 Not yet recruiting
NCT07328035 2026-01-13
Remission in Adults With Severe Asthma in Thailand
Thammasat University
Not yet recruiting
NCT07334873 2026-01-13
ENARCT-ARDS
Nanfang Hospital, Southern Medical University
Phase NA Not yet recruiting
NCT07299149 2025-12-23
ZGR in TN FL
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Not yet recruiting
NCT06985576 2025-12-18
Long-term Study to Evaluate Safety and Persistence of GF-CART01
GenomeFrontier Therapeutics TW Co., Ltd.
Not yet recruiting
NCT07225439 2025-11-06
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Case Comprehensive Cancer Center
Phase 1 Not yet recruiting
NCT07215910 2025-10-14
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Not yet recruiting
NCT07197021 2025-09-29
Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)
Sun Yat-sen University
Phase EARLY_PHASE1 Not yet recruiting
NCT07197307 2025-09-29
CLEAR
Universität Münster
Phase 2 Not yet recruiting
NCT07191249 2025-09-24
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
Tel-Aviv Sourasky Medical Center
Phase 2 Not yet recruiting
NCT07187960 2025-09-23
Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Not yet recruiting
NCT07168291 2025-09-17
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1 Not yet recruiting
NCT07123311 2025-08-14
Implementation and Evaluation of an Internet-Based Stress Management Program for Health Students in the Sfax Region
University of Sfax
Phase NA Not yet recruiting
NCT05974202 2025-08-03
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
New York State Psychiatric Institute
Phase NA Not yet recruiting
NCT07092852 2025-07-30
PGx Medication Safety Reviews of Persons With IDD
GalenusRx, Inc.
Not yet recruiting
NCT06971848 2025-07-11
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT07031700 2025-06-22
A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07024147 2025-06-17
JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & Institute
Phase 1 Not yet recruiting
NCT07011966 2025-06-10
ASV Therapy for Insomnia
ResMed
Phase NA Not yet recruiting
NCT06976827 2025-05-16
DENUTADOM
Centre hospitalier Henri Mondor d'Aurillac
Phase NA Not yet recruiting
NCT06958770 2025-05-06
Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes
National Taiwan University Hospital
Not yet recruiting
NCT06878313 2025-03-14
Role of Elastic Power in Acute Respiratory Distress Syndrome
Hospital El Cruce
Not yet recruiting
NCT06264362 2025-03-11
Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia
Drexel University
Phase NA Not yet recruiting
NCT06757894 2025-01-03
Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06734624 2024-12-16
The Microbiome in Blood Cancer and HLH
University of Nottingham
Not yet recruiting
NCT06549335 2024-10-15
Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
Ruijin Hospital
Phase 2 Not yet recruiting
NCT06468215 2024-07-16
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
Peking University People's Hospital
Phase NA Not yet recruiting
NCT04827290 2024-04-04
CKD AGE
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Phase NA Not yet recruiting
NCT06142188 2023-11-21
Relmacabtagene Autoleucel in Hematologic Malignancies
Shanghai Ming Ju Biotechnology Co., Ltd.
Not yet recruiting
NCT05616325 2022-11-15
FERTILymph
University Hospital, Lille
Not yet recruiting
NCT02194751 2021-04-08
Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma
XEME Biopharma Inc.
Phase 2 Not yet recruiting